Ciclosporin topical - Spherium Biomed

Drug Profile

Ciclosporin topical - Spherium Biomed

Alternative Names: Ciclosporin 5% topical solution; Cyclosporine 5% topical solution; SP14019; SP14019-F-01

Latest Information Update: 27 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Spherium Biomed
  • Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis
  • Clinical Phase Unknown Psoriasis

Most Recent Events

  • 01 Sep 2016 Phase-II clinical trials in Atopic dermatitis in Spain (Topical) (NCT02865356)
  • 29 Aug 2016 Clinical trials in Atopic dermatitis in Spain (Topical) prior to August 2016
  • 29 Aug 2016 Clinical trials in Psoriasis in Spain (Topical) prior to August 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top